USNA Company Profile and Key Details

Q: Who are the executives of USNA?

Mr. G. Douglas HekkingChief Financial OfficerDr. Myron W. WentzFounder & Chairman EmeritusMr. Walter NootChief Operating OfficerMr. Patrique RichardsExecutive Director of Investor Relations & Bus. Devel.Mr. David MulhamChief Sales OfficerDr. Robert A. SinnottChief Scientific OfficerMr. P. Joshua FoukasChief Legal Officer, Gen. Counsel & Corporation Sec.Dr. Robert A. Sinnott M.N.S., Ph.D.Chief Scientific OfficerDr. John CuomoExecutive Director of Product Devel. & TechnologyMr. Kevin G. GuestExecutive Chairman

NYSE : USNA

USANA Health Sciences

$21.78

0.27+1.26%

At Close 4:00 PM

55.89

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

USANA Health Sciences, Inc. (USNA) stock surged +1.26%, trading at $21.78 on NYSE, up from the previous close of $21.51. The stock opened at $21.67, fluctuating between $20.88 and $21.91 in the recent session.

Stock Snapshot

21.51

Prev. Close

402.12M

Market Cap

20.88

Day Low

12.1

P/E Ratio

1.8

EPS (TTM)

2.94

Cash Flow per Share

21.67

Open

18.46M

Number of Shares

21.91

Day High

52.44%

Free Float in %

25.99

Book Value

64.55K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 06, 2026	21.73	21.99	20.96	21.78	85.44K
Jul 02, 2026	21.76	21.93	21.09	21.51	95.54K
Jul 01, 2026	21.44	21.93	21.23	21.72	91.52K
Jun 30, 2026	20.79	21.42	20.32	21.35	89.29K
Jun 29, 2026	20.70	21.40	20.37	21.01	144.19K
Jun 26, 2026	19.75	20.84	19.75	20.70	322.01K
Jun 25, 2026	19.72	19.82	19.52	19.68	97.2K
Jun 24, 2026	19.35	20.17	19.35	19.94	77.22K
Jun 23, 2026	18.93	19.40	18.93	19.20	64.69K
Jun 22, 2026	18.96	19.27	18.84	18.90	88.99K
Jun 18, 2026	18.63	19.34	18.55	18.88	227.81K
Jun 17, 2026	19.01	19.47	18.27	18.40	149.44K
Jun 16, 2026	19.59	19.78	19.01	19.01	89.34K
Jun 15, 2026	20.28	20.32	19.28	19.41	153.34K
Jun 12, 2026	20.05	20.25	19.84	19.91	86.91K
Jun 11, 2026	19.35	20.03	19.01	19.87	123.59K
Jun 10, 2026	19.11	19.39	18.48	19.17	101.3K
Jun 09, 2026	18.71	19.29	18.38	19.01	112.49K
Jun 08, 2026	18.22	18.82	17.97	18.70	95.88K
Jun 05, 2026	18.18	18.49	17.86	18.03	86.01K

Contact Details

Salt Lake City, UT 84120

United States

https://www.usana.com 801 954 7100

About Company

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

Stock Peers

-2.1-1.39%

The Procter & Gamble Company$149.31 CHD

-1.15-1.17%

Church & Dwight Co., Inc.$97.45 CLX

-0.01-0.01%

The Clorox Company$97.25 CL

-1.74-1.83%

Colgate-Palmolive Company$93.39 EL

1.19+1.42%

The Estée Lauder Companies Inc.$84.90 SPB

-1.55-1.82%

Spectrum Brands Holdings, Inc.$83.44 SGI

-0.23-0.29%

Somnigroup International Inc$78.20 ELF

-2.93-3.83%

e.l.f. Beauty, Inc.$73.49 UL

-0.9-1.44%

Unilever PLC$61.58 EPC

-0.54-1.98%

Edgewell Personal Care Company$26.67

Company Overview

USANA Health Sciences, Inc. (NYSE:USNA) closed at $21.78 USD, gaining $0.27 (1.26%) from the previous close of $21.51. The stock is currently mid-range between its 52-week high and low $16.60 and $38.32. With a market capitalization of about $402.12 million, USANA Health Sciences, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.73). Key stats such as the average daily volume over the past year has been around 114.83 thousand shares, volume is running light vs its 52-week average. Headquartered in Salt Lake City, UT, USANA Health Sciences, Inc. operates in the Consumer Defensive sector and the Household & Personal Products industry. Led by CEO Kevin G. Guest, the company employs approximately 1,570 people and listed since April 04, 1994. USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 0.3%, SMA50 1.83%, SMA200 -17.32%). The stock’s 14-day RSI is 50.79 (neutral), while the ATR of 1.04 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -44.78% below its high and over 14.5% above its low. Average 10-day trading volume of 138.00 thousand shares is slightly above the 3-month average of 115.65 thousand, indicating heightened recent market interest.

Valuation Metrics

USANA Health Sciences, Inc. trades at a P/E ratio of 45.73, slightly above the S&P 500 average, with a price-to-sales ratio of 0.43 and a price-to-book ratio of 0.73 suggesting the stock is closer to book value. The P/FCF stands at 134.87, also above market averages.

Dividend & Fair Value

USANA Health Sciences, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $61.78. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

USANA Health Sciences, Inc. generated EPS of $0.56 over the past year. Five-year average earnings growth is -37.06%. The latest quarter delivered EPS of $0.61. The next quarter is forecast at $0.44. Next year's EPS is expected at -$1.02. USANA Health Sciences, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended May 05, 2026, missed forecasts by 38.64%. The prior quarter beat by 46.34%. Over the last six quarters, Apple has recorded several small beats. These include 30.61% in February 25, 2025.

Shareholding & Insider Activity

USANA Health Sciences, Inc. has 18.27 million shares outstanding. The public float is 9.58 million shares, elevated short interest at 6.76% of float. This equals 704.74 thousand shares. The short ratio is 6.7 days. Institutional investors hold 95.48% of the float. Insiders own 40.86%. WENTZ MYRON W holds 7.86 million shares, Brown Jim has 15.72 thousand shares and Guest Kevin has 10.49 thousand shares. Over the past six months, insider transactions show net selling. They sold 42.62 thousand shares across 12 transactions.

Financial & Profitability Overview

Over the trailing twelve months, USANA Health Sciences generated $921.01M in revenue, or $47.61 per share. Gross margin was 79.44%, operating margin 10.11%, and net profit margin 6.93%. Returns are healthy, with ROA at 10.08% and ROE at 12.83%.
On valuation metrics, USANA Health Sciences trades at a P/E of 45.73, P/S of 0.43 and P/B of 0.73. The current ratio is 2.51 and quick ratio is 1.69. Operationally, the company’s inventory turnover is 2.24 and cash conversion cycle is 139.47 days. Debt-to-equity is 0.03, supported by a cash flow-to-debt ratio of 1.19.

Quarterly Financial Highlights

For the quarter ended Dec 30, 2023, USANA Health Sciences posted revenue of $921.01M, down slightly from $998.60M in the prior quarter. Gross profit was $731.62M (margin 79.44%). Operating income was $93.07M (margin 10.1%). Net income was$63.79M (EPS $3.31).
The company ended the quarter with $330.42M in cash and short-term investments, a total debt of $13.21M, and net debt of - $317.22M. Total assets were $632.76M, with equity of $497.20M. Financials further reflected stability, with operating cash flow of $70.64M, free cash flow of $56.15M, and capital expenditures of - $14.49M.

Price Forecast & Outlook

Our AI price prediction model suggests that USANA Health Sciences, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 7.35%, with price expected at $23.38 by July 16, 2026, within a range of $22.76 to $23.98 3-Month Outlook: Projected rise of 5.28%, reaching $22.93 by September 30, 2026, with a range of $21.20 to $24.29. 1-Year Outlook: Projected loss of -80.81%, with price at $4.18 by July 02, 2027, within a range of $2.84 to $5.29.

Key Takeaways

USANA Health Sciences, Inc. (NYSE:USNA) shares are up 11.92% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows USANA Health Sciences, Inc. trading at a premium to the broader market with a P/E of 45.73. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $83.98, suggesting 285.58% upside. Our AI forecast model points to short-term strength (7.35% over two weeks), a medium-term rise (5.28% over three months), and a longer-term loss (-80.81% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current USANA Health Sciences, Inc. (USNA) stock price?

USANA Health Sciences, Inc. (NYSE: USNA) stock price is $21.78 in the last trading session. During the trading session, USNA stock reached the peak price of $21.91 while $20.88 was the lowest point it dropped to. The percentage change in USNA stock occurred in the recent session was 1.26% while the dollar amount for the price change in USNA stock was $0.27.

USNA's industry and sector of operation?

The NYSE listed USNA is part of Household & Personal Products industry that operates in the broader Consumer Defensive sector. USANA Health Sciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of USNA?

Mr. G. Douglas Hekking
Chief Financial Officer
Dr. Myron W. Wentz
Founder & Chairman Emeritus
Mr. Walter Noot
Chief Operating Officer
Mr. Patrique Richards
Executive Director of Investor Relations & Bus. Devel.
Mr. David Mulham
Chief Sales Officer
Dr. Robert A. Sinnott
Chief Scientific Officer
Mr. P. Joshua Foukas
Chief Legal Officer, Gen. Counsel & Corporation Sec.
Dr. Robert A. Sinnott M.N.S., Ph.D.
Chief Scientific Officer
Dr. John Cuomo
Executive Director of Product Devel. & Technology
Mr. Kevin G. Guest
Executive Chairman

How USNA did perform over past 52-week?

USNA's closing price is 31.2% higher than its 52-week low of $16.60 where as its distance from 52-week high of $38.32 is -43.16%.

How many employees does USNA have?

Number of USNA employees currently stands at 1,570.

Link for USNA official website?

Official Website of USNA is: https://www.usana.com

How do I contact USNA?

USNA could be contacted at phone 801 954 7100 and can also be accessed through its website. USNA operates from 3838 West Parkway Boulevard, Salt Lake City, UT 84120, United States.

How many shares of USNA are traded daily?

USNA stock volume for the day was 64.55K shares. The average number of USNA shares traded daily for last 3 months was 114.83K.

What is the market cap of USNA currently?

The market value of USNA currently stands at $402.12M with its latest stock price at $21.78 and 18.46M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1570
Beta	0.77
Sales or Revenue	$921.01M
5Y Sales Change%	-0.052%
Fiscal Year Ends	December
Sector	Consumer Defensive
Industry	Household & Personal Products

USNA Company Profile and Key Details

USANA Health Sciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways